Antonio Casado Herráez

Profesor titular

Universidad Complutense de Madrid

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Antonio Casado Herráez is a Profesor titular at Universidad Complutense de Madrid, Spain. His research areas include sarcoma management, health-related quality of life assessment in oncology, and the interplay of immunotherapy and antiangiogenics in ovarian cancer. His recent publications focus on clinical guidelines, patient-centered research, and genomic signatures related to cancer outcomes.

Articles (7)

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Mariona Baliu-Piqué

Head

SPAIN

View details

Dagmara Kulis

Associate Head and QOL Tools Team Leader

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Antonio Casado Herráez

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Incorporating the patient voice in sarcoma research: How can we assess health-related quality of life in this heterogeneous group of patients? a study protocol

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)

A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum-Sensitive Ovarian Cancer

A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)

Are antiangiogenics a good ‘partner’ for immunotherapy in ovarian cancer?

Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors

Usefulness of omalizumab in rapid drug desensitization in patients with severe anaphylaxis induced by carboplatin: Open questions

Collaborators (2)

Mariona Baliu-Piqué

Dagmara Kulis

Make your next move.